MD, PhD (President)
President: The Japanese Society for Vascular Cognitive Impairment
I am Dr. Ryuichi Morishita from Osaka University, and I took over as President of the Japanese Society for Vascular Cognitive Impairment from Dr. Koji Abe. I would like to further develop this society - which was first developed by Dr. Nagata, the first President, and Dr. Abe, the second President - to the best of my ability, with the cooperation of all the members in our society, so your kind support would be greatly appreciated.
Vas-Cog Japan, which is in its eighth year from its time as a study group, has developed quite considerably. As our society has already met the requirements to be registered as an academic organization in the Science Council of Japan with regard to the number of members, membership management and publication of journals, the Chairman for the Promotion of Becoming a Society, Dr. Katsuya Urakami, has been working on our application for the registration.
Also, our newsletter, which was first published in 2016 in Japanese and English, has been distributed to related academic societies in various countries and is well received thanks to the hard work by former President Dr. Abe. Fortunately, thanks to the efforts of the Chief Editor of the academic magazine, Dr. Mikio Shoji, it has developed into Vas-Cog Journal, a joint publication with Vas-Cog Asia.
In addition, the number of members also increased steadily due to the efforts of the Chairman for Increasing Membership and Public Relations, Dr. Haruo Hanyu. As of August 2017, we have 143 active members, including 26 directors and 54 councilors and the membership is expected to increase in the future. Furthermore, the financial structure has been going very well. I sincerely thank the members, councilors, and directors who have supported this society for all these achievements.
I would like to continue to strengthen the financial structure under the guidance of Dr. Yoshio Ikeda, who is the newly appointed Chairman of Financial Affairs. Regarding conflicts of interest, we plan to set up a COI committee and prepare provisions under the direction of the Chairman, Dr. Masahiko Suzuki.
The 8th Annual Meeting of Vas-Cog Japan was held with great success on August 5, 2017, at Toranomon Hills, with Dr. Shinichiro Uchiyama and Dr. Issei Komuro as chairmen. I believe that many participants were satisfied with the very attractive program at a great venue organized by the chairmen. The 9th annual meeting is to be held at Beppu International Convention Center August 4-5, 2018, with Dr. Katsuya Urakami and Dr. Etsuro Matsubara as chairmen, so we are expecting many of you to attend.
Our affiliate Vas-Cog Asia has been revitalizing year by year. The 6th meeting held in Nanjing City on October 26, 2017, was a huge success with Vas-Cog Asia Director, Dr. Koji Abe and Dr. Shinichiro Uchiyama serving as lecturers and moderators. The 7th annual meeting will be held in Jakarta on September 6, 2018. Vas-Cog World will also be held in Hong Kong November 24-27, 2018.
With regard to the major dementias such as Lewy body dementia, Parkinson's Disease-related dementia and frontotemporal dementia, as well as the rapidly increasing Alzheimer's Disease (AD) and vascular dementia, Vas-Cog Japan has been established to elucidate the relationship between blood vessels and dementia that are attracting attention in our rapidly aging society with the aim of advancing clinical and fundamental research from a new broader viewpoint beyond the concept that it is merely a vascular dementia as classified conventionally.
As the government has set the era of a lifetime at one hundred years, prevention and treatment of dementia is becoming a top priority task, such as the development of health care strategy for a one-year extension of life expectancy by 2020. In addition, Japan is bidding to host the World Exposition in Osaka in 2025
In response to such new academic and social demands, our society will continue to elucidate the deep linkage between functional and organic obstacles in blood vessels and the onset of dementia, and will develop new diagnostic and therapeutic methods. By doing so, we aim to contribute to the maintenance and development of a healthily aging society of all human beings, including Japanese.
Our society has developed steadily under the leadership of former Presidents Dr. Nagata and Dr. Abe. It is a unique academic society that covers a wide variety of interdisciplinary fields such as cardiology, neurology, and brain surgery through the active participation of everyone, so we are looking forward to the participation of many of you.
April 1, 2018